These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25916213)

  • 1. Association of diabetes and diabetes treatment with incidence of breast cancer.
    García-Esquinas E; Guinó E; Castaño-Vinyals G; Pérez-Gómez B; Llorca J; Altzibar JM; Peiró-Pérez R; Martín V; Moreno-Iribas C; Tardón A; Caballero FJ; Puig-Vives M; Guevara M; Villa TF; Salas D; Amiano P; Dierssen-Sotos T; Pastor-Barriuso R; Sala M; Kogevinas M; Aragonés N; Moreno V; Pollán M
    Acta Diabetol; 2016 Feb; 53(1):99-107. PubMed ID: 25916213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and Breast Cancer Subtypes.
    Bronsveld HK; Jensen V; Vahl P; De Bruin ML; Cornelissen S; Sanders J; Auvinen A; Haukka J; Andersen M; Vestergaard P; Schmidt MK
    PLoS One; 2017; 12(1):e0170084. PubMed ID: 28076434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
    Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes.
    Kim HJ; Kwon H; Lee JW; Kim HJ; Lee SB; Park HS; Sohn G; Lee Y; Koh BS; Yu JH; Son BH; Ahn SH
    Breast Cancer Res; 2015 May; 17(1):64. PubMed ID: 25935404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, metformin, and breast cancer in postmenopausal women.
    Chlebowski RT; McTiernan A; Wactawski-Wende J; Manson JE; Aragaki AK; Rohan T; Ipp E; Kaklamani VG; Vitolins M; Wallace R; Gunter M; Phillips LS; Strickler H; Margolis K; Euhus DM
    J Clin Oncol; 2012 Aug; 30(23):2844-52. PubMed ID: 22689798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes.
    Chikermane SG; Sharma M; Abughosh SM; Aparasu RR; Trivedi MV; Johnson ML
    Breast Cancer Res Treat; 2022 Oct; 195(3):421-430. PubMed ID: 35969285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes.
    Crispo A; Augustin LS; Grimaldi M; Nocerino F; Giudice A; Cavalcanti E; Di Bonito M; Botti G; De Laurentiis M; Rinaldo M; Esposito E; Riccardi G; Amore A; Libra M; Ciliberto G; Jenkins DJ; Montella M
    J Cell Physiol; 2017 May; 232(5):1144-1150. PubMed ID: 27579809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus, metformin and head and neck cancer.
    Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V
    Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
    Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
    Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.
    Hou G; Zhang S; Zhang X; Wang P; Hao X; Zhang J
    Breast Cancer Res Treat; 2013 Feb; 137(3):807-16. PubMed ID: 23292119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.
    Gong Z; Aragaki AK; Chlebowski RT; Manson JE; Rohan TE; Chen C; Vitolins MZ; Tinker LF; LeBlanc ES; Kuller LH; Hou L; LaMonte MJ; Luo J; Wactawski-Wende J
    Int J Cancer; 2016 Apr; 138(8):1915-27. PubMed ID: 26616262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer.
    Sellers TA; Anderson KE; Olson JE; Folsom AR
    Epidemiology; 1998 Jan; 9(1):102-5. PubMed ID: 9430278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metformin on the incidence of head and neck cancer in diabetics.
    Yen YC; Lin C; Lin SW; Lin YS; Weng SF
    Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.
    Puig-Vives M; Sánchez MJ; Sánchez-Cantalejo J; Torrella-Ramos A; Martos C; Ardanaz E; Chirlaque MD; Perucha J; Díaz JM; Mateos A; Machón M; Marcos-Gragera R
    Gynecol Oncol; 2013 Sep; 130(3):609-14. PubMed ID: 23747837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.
    Nelson SE; Gould MN; Hampton JM; Trentham-Dietz A
    Breast Cancer Res; 2005; 7(3):R357-64. PubMed ID: 15987431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between weight in early adulthood, change in weight, and breast cancer risk in postmenopausal women.
    Krishnan K; Bassett JK; MacInnis RJ; English DR; Hopper JL; McLean C; Giles GG; Baglietto L
    Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1409-16. PubMed ID: 23720403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.
    Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Wolk A
    Int J Cancer; 2006 Oct; 119(7):1683-9. PubMed ID: 16646051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.